Page last updated: 2024-08-21

1,2,4-triazole and Pancreatic Neoplasms

1,2,4-triazole has been researched along with Pancreatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Y; Gu, H; Guan, T; He, P; He, Y; Kan, W; Li, Y; Yi, Z; Zhang, T1
Chen, Y; Guo, W; He, Y; Krimm, I; Li, Y; Liu, M; Mi, D; Pei, H; Shao, T; Wang, P; Wang, X; Yi, Z; Zhang, Y1

Other Studies

2 other study(ies) available for 1,2,4-triazole and Pancreatic Neoplasms

ArticleYear
Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.
    Future medicinal chemistry, 2022, Volume: 14, Issue:20

    Topics: Antineoplastic Agents; Calcium-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Membrane Proteins; Molecular Docking Simulation; Muscle Proteins; Pancreatic Neoplasms; Structure-Activity Relationship; Water

2022
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
    Journal of medicinal chemistry, 2019, 05-23, Volume: 62, Issue:10

    Topics: Animals; Antineoplastic Agents; Calcium-Binding Proteins; Cell Line, Tumor; Cell Movement; Drug Design; Epithelial-Mesenchymal Transition; Humans; Membrane Proteins; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Muscle Proteins; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Structure-Activity Relationship; Triazoles; Xenograft Model Antitumor Assays

2019